Journal of Jilin University Medicine Edition ›› 2016, Vol. 42 ›› Issue (03): 622-625.doi: 10.13481/j.1671-587x.20160340
Previous Articles Next Articles
Received:
2015-12-16
Published:
2016-06-17
CLC Number:
[1] Gordon S. Alternative activation of macrophages[J].Nat Rev Immunol, 2003, 3(1): 23-35.[2] Hao NB,Lu MH,Fan YH, et al. Macrophages in tumor microenvironments and the progression of tumors[J]. Clin Dev Immunol, 2012, 2012:948098.[3] Cassetta L, Cassol E, Poli G. Macrophage polarization in health and disease[J]. Scientific World J, 2011, 11:2391-2402.[4] Chávez-Galán L, Olleros ML, Vesin D, et al. Much more than M1 and M2 macrophages, there are also CD169(+) and TCR(+) macrophages[J]. Front Immunol,2015, 6:263.[5] Biswas SK, Lopez-Collazo E. Endotoxin tolerance: new mechanisms, molecules and clinical significance[J]. Trends Immunol, 2009, 30(10): 475-487.[6] Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties[J]. Immunity, 2003, 19(1): 71-82.[7] Darnell JE Jr, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins[J]. Science, 1994, 264(5164): 1415-1421.[8] Park C, Li S, Cha E, et al. Immune response in Stat2 knockout mice[J]. Immunity, 2000, 13(6): 795-804.[9] Brombacher F, Arendse B, Peterson R, et al. Analyzing classical and alternative macrophage activation in macrophage/neutrophil-specific IL-4 receptor-alpha-deficient mice[J]. Methods Mol Biol, 2009: 531:225-252.[10] Martinez FO, Helming L, Gordon S. Alternative activation of macrophages: an immunologic functional perspective[J]. Annu Rev Immunol, 2009, 27: 451-483.[11] Olefsky JM, Glass CK. Macrophages, inflammation, and insulin resistance[J]. Annu Rev physiol, 2010, 72: 219-246.[12] Pascual G, Fong AL, Ogawa S, et al. A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma[J]. Nature, 2005, 437(7059): 759-763.[13] Odegaard JI, Ricardo-Gonzalez RR, Goforth MH, et al. Macrophage-specific PPARγ controls alternative activation and improves insulin resistance[J].Nature, 2007,447(7148):1116-1120 .[14] Szanto A, Balint BL, Nagy ZS, et al. STAT6 transcription factor is a facilitator of the nuclear receptor PPARγ-regulated gene expression in macrophages and dendritic cells[J]. Immunity, 2010, 33(5): 699-712.[15] El Kasmi KC, Qualls JE, Pesce JT, et al. Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens[J]. Nat Immunol, 2008, 9(12): 1399-1406.[16] Hu HM, Baer M, Williams SC, et al. Redundancy of C/EBP, and in supporting the lipopolysaccharideinduced transcription of IL-6 and monocyte chemoattractant 1[J]. J Immunol, 1998,160(5): 2334-2342 .[17] Kim C,Wilcox-Adelman S,Sano Y, et al. Anti-inflammatory cAMP signaling and cell migration genes coopted by the anthrax bacillus[J]. Proc Natl Acad Sci USA, 2008, 105(16):6150-6155.[18] Marigo I, Bosio E, Solito S, et al. Tumor-induced tolerance and immune suppression depend on the C/EBPβ transcription factor[J]. Immunity, 2010, 32(6): 790-802.[19] Savitsky D, Tamura T, Yanai H, et al. Regulation of immunity and oncogenesis by the IRF transcription factor family[J]. Cancer Immunol Immunother, 2010, 59(4): 489-510.[20] De Santa F, Totaro MG, Prosperini E, et al. The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing[J]. Cell, 2007, 130(6): 1083-1094.[21] Van der Valk P, De Groot CJ. Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS[J]. Neuropathol Appl Neurobiol, 2000, 26(1): 2-10.[22] Rawji KS, Yong VW. The benefits and detriments of macrophages/microglia in models of multiple sclerosis[J]. Clin Dev Immunol, 2013, 2013:948976.[23] Hughes JE, Srinivasan S, Lynch KR, et al. Sphingosine-1-phosphate induces an anti- inflammatory phenotype in macrophages[J]. Circ Res, 2008, 102(8): 950-958.[24] Kopadze T, Dehmel T, Hartung HP, et al. Inhibition by mitoxantrone of in vitro migration of immunocompetent cells: a possible mechanism for therapeutic efficacy in the treatment of multiple sclerosis[J]. Arch Neurol, 2006, 63(11): 1572-1578.[25] Jung S, Siglienti I, Grauer O, et al. Induction of IL-10 in rat peritoneal macrophages and dendritic cells by glatiramer acetate[J]. J Neuroimmunol, 2004, 148(1): 63-73.[26] Coussens LM, Zitvogel L, Palucka AK. Neutralizing tumor-promoting chronic inflammation: a magic bullet?[J]. Science, 2013, 339(6117): 286-291.[27] Noy R, Pollard JW. Tumor-associated macrophages: from mechanisms to therapy [J]. Immunity, 2014, 41(1): 49-61.[28] Yang XD, Ai W, Asfaha S, et al. Histamine deficiency promotes inflammation-associated carcinogenesis through reduced myeloid maturation and accumulation of CD11b+ Ly6G+ immature myeloid cells[J]. Nat Med, 2011, 17(1): 87-95.[29] Cohen NA, Zeng S, Kim TS, et al. Angiogenesis inhibition augments the effect of imatinib in gastrointestinal stromal tumor[J]. J Am Coll Surgeons, 2013, 217(3): S140.[30] Monini P, Colombini S, Stürzl M, et al. Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma[J]. Blood, 1999, 93(12): 4044-4058.[31] Escamilla J, Schokrpur S, Liu C, et al. CSF1 receptor targeting in prostate cancer reverses macrophage-mediated resistance to androgen blockade therapy[J]. Cancer Res, 2015, 75(6): 950-962.[32] Duluc D, Corvaisier M, Blanchard S, et al. Interferon-gamma reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor-associated macrophages[J]. Int J Cancer, 2009, 125(2): 367-373.[33] Rolny C, Mazzone M, Tugues S, et al. HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF[J]. Cancer Cell, 2011, 19(1): 31-44.[34] Apter AJ. Advances in adult asthma diagnosis and treatment in 2013[J]. J Allergy Clin Immunol, 2014, 133(1): 49-56.[35] Careau E, Bissonnette EY. Adoptive transfer of alveolar macrophages abrogates bronchial hyperresponsiveness[J]. Am J Resp Cell Mol, 2004, 31(1): 22-27.[36] Alexis NE, Soukup J, Nierkens S, et al. Association between airway hyperreactivity and bronchial macrophage dysfunction in individuals with mild asthma[J]. Am J Physiol-Lung C, 2001, 280(2): L369-L375.[37] Moreira AP, Cavassani KA, Hullinger R, et al. Serum amyloid P attenuates M2 macrophage activation and protects against fungal spore-induced allergic airway disease[J]. J Allergy Clin Immunol, 2010, 126(4): 712-721,e7. |
[1] | ZHENG Quanhui, LEI Bing, YUAN Hongru, MA Jiannan, LIU Zhaoji, ZHANG Jun, LIU Yibo, ZHANG Bing, ZHANG Aihong, ZHENG Aihua, ZHANG Ying, LI Huiting, TIAN Feng. Regulatoy effects of HDAC3 on development and function of iNKT cells [J]. Journal of Jilin University(Medicine Edition), 2020, 46(02): 205-213. |
[2] | WANG Juan,XIE Fei,CHEN Tan-xiu,SUN Xia-xia,LI Qiong-shu,TAI Gui-xiang . Evaluation on effect of ultrafiltration technology on endotoxin removal from recombinant MUC1-MBP fusion protein [J]. Journal of Jilin University Medicine Edition, 2014, 40(03): 539-542. |
[3] | ZHANG Peng,WANG Yan-li,GUO Shi-wen,LIU En-qi. Cloning of rabbit cholesteryl ester transfer protein gene andconstruction of its eukaryotic expression vector [J]. Journal of Jilin University Medicine Edition, 2013, 39(4): 837-840. |
[4] | . Proliferative effect of |Cp G ODN with differentsequences on human periodental ligament cells [J]. J4, 2012, 38(5): 876-879. |
[5] | QI Yue,JIN Qing-long,WEN Xiao-yu,NIU Jun-qi. Expression of constitutive IRF7 in hepatocytes and its anti-viral function [J]. J4, 2012, 38(2): 183-186. |
[6] | SUN Lin, WU Xiu-Li, WANG Li-Ying, YU Yong-Li. Molecular mimicry of murine pancreas by HSP65-MUC1 [J]. J4, 2011, 37(1): 15-17. |
[7] | LI He, WANG Hua, WU Xiu-Li, WEI Hong-Fei, SUN Liu-Guan, ZHANG Yong-Sheng, YU Yong-Li, WANG Li-Ying, WU Min. Effect of BCG-derived HSP70 on immunogenicity of tumor cell lysate [J]. J4, 2011, 37(1): 68-71. |
[8] | DU Bo, MIAO Lan-Fang, SU xue-Jin, ZHU Zhe, WANG Lin. Construction and functional identification of |interleukin-2 gene expression plasmid with RU486 inducible system [J]. J4, 2010, 36(3): 469-472. |
[9] | LI He, ZHANG Pei-Yin, WEI Gong-Fei, CAO Zhao, WANG Ying, WANG Hua, HU Xiao-Peng, WAN Min, WANG Li-Ying, YU Yong-Li. Purification of recombinant BCG heat shock protein 70 and evaluation of effect on endotoxin removal [J]. J4, 2010, 36(1): 35-39. |
[10] | LI Jing,JIANG Zheng,CHEN Li,SUN Hai-bo. Effect of down-regulating survivin expression by RNAi on growth suppression and promotion on apoptosis of human hepatocellular carcinoma cells [J]. J4, 2009, 35(1): 73-77. |
[11] | ZHANG Xue-song, HU Da-li, SUN Ran, YANG Guang,WANG Hua-ying, WANG Li-ying, YU Yong-li. Sequence designation and screening of novel immunoregulatory oligodeoxynucleotides [J]. J4, 2008, 34(3): 389-392. |
[12] | FANG Yan-qiu,QI Ya-ling,YAN Li,TAN Yan,DUAN Xiu-mei,XU Shu-fen,LIU Jin-sha. Comparison of cytotoxicity of tumor specific CTL inducedby IL-18 and IL-12 in cell co-culture system in vitro [J]. J4, 2007, 33(6): 1033-1037. |
[13] | GAO Yan-guang,FEI Jun-wei,FEI Rui,ZENG Xian-lu. Prokaryotic expression of human L-selectin and preparation of polyclonal antibody [J]. J4, 2006, 32(1): 145-5. |
[14] | LI Zi-jian, JIN Ning-yi, ZHANG Li-shu, JIANG Wen-zheng,ZHANG Hong-yong, LI Chang. Higher immune response inflicted by combined immunization of HIV-2 gp105 [J]. J4, 2006, 32(1): 1-3. |
[15] | PENG Li-ping, HUA Shu-cheng, CHI Bao-rong. Effects of CTLA4-Ig on IL-13 in peripheral blood of patients with bronchial asthma [J]. J4, 2005, 31(1): 100-103. |
|